Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 7/20 | 0.70 |
| ▸ | CA1 | P00915 | 7/20 | 0.70 |
| ▸ | CA2 | P00918 | 7/20 | 0.70 |
| ▸ | CA7 | P43166 | 7/20 | 0.70 |
| ▸ | CA9 | Q16790 | 7/20 | 0.70 |
| ▸ | CA14 | Q9ULX7 | 7/20 | 0.70 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.62 |
| ▸ | ESR1 | P03372 | 1/20 | 0.56 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.56 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.47 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10570974 | 0.90 | CA12 (0.74) | CA12CA1CA2CA7CA9 | |
| SCHEMBL9252178 | 0.88 | MCL1 (0.62) | CA12CA1CA2CA7CA9 | |
| SCHEMBL6970075 | 0.87 | CA12 (0.70) | CA12CA1CA2CA7CA9 | |
| SCHEMBL2292998 | 0.86 | CA12 (0.59) | CA12CA1CA2CA7CA9 | |
| SCHEMBL403798 | 0.85 | CA1 (0.68) | CA12CA1CA2CA7CA9 | |
| SCHEMBL8669772 | 0.85 | CA12 (0.57) | CA12CA1CA2CA7CA9 | |
| SCHEMBL1353933 | 0.85 | CA12 (0.57) | CA12CA1CA2CA7CA9 | |
| SCHEMBL9136311 | 0.84 | MEN1 (0.62) | CA12CA1CA2CA7CA9 | |
| SCHEMBL3918302 | 0.83 | CA12 (0.56) | CA12CA1CA2CA7CA9 | |
| SCHEMBL7013424 | 0.83 | CA12 (0.64) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107935840-B | 4-hydroxyisophthalic acid derivative and synthetic method thereof | 常州工程职业技术学院 | 2021-05-25 | — | — | CN | claimed |
| US-9688807-B2 | Epoxy resin system containing polyethylene tetraamines for resin transfer molding processes | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-06-27 | — | — | US | claimed |
| EP-2920227-B1 | EPOXY RESIN SYSTEM CONTAINING POLYETHYLENE TETRAAMINES FOR RESIN TRANSFER MOLDING PROCESSES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-02-08 | — | — | EP | claimed |
| US-9440891-B2 | Palladium-catalyzed decarbonylation of fatty acid anhydrides for the production of linear alpha olefins | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2016-09-13 | — | — | US | claimed |
| EP-2920227-A1 | EPOXY RESIN SYSTEM CONTAINING POLYETHYLENE TETRAAMINES FOR RESIN TRANSFER MOLDING PROCESSES | Dow Global Technologies LLC (US) | 2015-09-23 | — | — | EP | claimed |
| US-20150240025-A1 | EPOXY RESIN SYSTEM CONTAINING POLYETHYLENE TETRAAMINES FOR RESIN TRANSFER MOLDING PROCESSES | DOW EUROPE GMBH (CH) | 2015-08-27 | — | — | US | claimed |
| WO-2014078219-A1 | EPOXY RESIN SYSTEM CONTAINING POLYETHYLENE TETRAAMINES FOR RESIN TRANSFER MOLDING PROCESSES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2014-05-22 | — | — | WO | claimed |
| CN-112159347-B | Preparation method of picolitamide | 常州工程职业技术学院 | 2022-06-07 | — | — | CN | disclosed |
| CN-107935840-B | 4-hydroxyisophthalic acid derivative and synthetic method thereof | 常州工程职业技术学院 | 2021-05-25 | — | — | CN | disclosed |
| CN-112159347-A | Preparation method of picolitamide | 常州工程职业技术学院 | 2021-01-01 | — | — | CN | disclosed |
| CN-109305976-A | Compound and its application as ACC inhibitor | 南京圣和药业股份有限公司 | 2019-02-05 | — | — | CN | disclosed |
| US-9688807-B2 | Epoxy resin system containing polyethylene tetraamines for resin transfer molding processes | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-06-27 | — | — | US | disclosed |
| EP-2920227-B1 | EPOXY RESIN SYSTEM CONTAINING POLYETHYLENE TETRAAMINES FOR RESIN TRANSFER MOLDING PROCESSES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-02-08 | — | — | EP | disclosed |
| US-6590118-B1 | Used in treatment of and/or prevention of diabetes, especially non-insulin dependent diabetes (Type 2 diabetes) | NOVO NORDISK A/S (DK) | 2003-07-08 | — | — | US | disclosed |
| CN-1391473-A | VLA-4 inhibitor compounds | DAIICHI SEIYAKU CO (JP) | 2003-01-15 | — | — | CN | disclosed |
| US-20020156061-A1 | Isophthalic acid derivatives as matrix metalloproteinase inhibitors | BARVIAN NICOLE CHANTEL (US) | 2002-10-24 | — | — | US | disclosed |
| WO-2002064547-A2 | ISOPHTHALIC ACID DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS | WARNER-LAMBERT COMPANY LLC (US) | 2002-08-22 | — | — | WO | disclosed |
| EP-1220832-A1 | NOVEL AROMATIC COMPOUNDS | NOVO NORDISK A/S (DK) | 2002-07-10 | — | — | EP | disclosed |
| WO-2001023347-A1 | NOVEL AROMATIC COMPOUNDS | NOVO NORDISK A/S (DK) | 2001-04-05 | — | — | WO | disclosed |
| US-4442176-A | CHROMOGEN, HYDROXYPHTHALIC DIESTER OF SPECIFIED MELTING POINT | KAWASAKI KASEI CHEMICALS LTD. (JP) | 1984-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020156061-A1 | Isophthalic acid derivatives as matrix metalloproteinase inhibitors | MMP13, MMP1, MMP11 | CA12 422/4885CA1 274/4885CA2 119/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.